Unknown

Dataset Information

0

A high-throughput liquid bead array assay confirms strong correlation between SARS-CoV-2 antibody level and COVID-19 severity.


ABSTRACT: A detailed understanding of the adaptive host response to SARS-CoV-2 infection in humans is urgently needed. We developed a sensitive, high-throughput, and efficient assay using liquid bead array technology. We observed advantages over traditional ELISA for the detection and quantification of binding IgG against the receptor binding domain (RBD) of SARS-CoV-2. To determine whether COVID-19 symptom severity correlates with SARS-CoV-2 IgG, we measured anti-RBD IgG levels from 67 subjects recovered from PCR-confirmed COVID-19. We found that COVID-19 symptom severity strongly correlated with RBD IgG level (p < 0.001). These findings have substantial implications for public policy surrounding assessments of antibody responses and possible immunity, as not all cases of COVID-19 can be assumed to generate a protective antibody response, and mild disease in particular is capable of generating very low-level anti-RBD IgG levels. These findings also have important implications for the selection of donors for convalescent plasma to be used therapeutically.

SUBMITTER: Bennett M 

PROVIDER: S-EPMC7836362 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4321376 | biostudies-literature
| S-EPMC6894145 | biostudies-literature
2020-07-31 | GSE145096 | GEO
| S-EPMC5772357 | biostudies-literature
| S-EPMC2650937 | biostudies-literature
| S-EPMC6069843 | biostudies-literature
| S-EPMC4604026 | biostudies-literature
| S-EPMC4150821 | biostudies-other
| S-EPMC3792038 | biostudies-literature
| S-EPMC8592674 | biostudies-literature